Prof. Guoyan Liu 刘国艳
Chief Physician, Professor
Department of Gynecologic Oncology, Tianjin Medical University Cancer Institute & Hospital, Tianjin
Public profile Compiled from public listings and PubMed. We do not work directly with this doctor, but we can find a specialist in this field to review your case.
Get a specialist opinionClinical focus: Diagnosis and treatment of gynecologic tumors, especially ovarian cancer, endometrial cancer, and cervical cancer. Also treats benign conditions such as endometriosis and uterine fibroids. Performs minimally invasive gynecologic surgery.
Dr. Liu holds a PhD in Obstetrics and Gynecology from Tianjin Medical University (2004) and was a visiting scholar at MD Anderson Cancer Center (2011–2012). Recipient of the 2014 USCACA-NFCR Academic Award. Leads two National Natural Science Foundation projects and one Tianjin Natural Science Foundation project. Published multiple SCI papers and over 20 articles in Chinese core journals.
Professional roles
- Member, Reproductive Tract Disease Diagnosis and Treatment Branch, National Eugenics Association
Name order: in Chinese the family name comes first (Liu Guoyan). Papers usually list the name as Guoyan Liu or Liu G.
Selected publications
17 papers on PubMed matched by name and affiliation; 14 as first or senior author since 2016. Most recent first- or senior-author papers:
- SLAS Technol, 2026 (senior author): Transcriptomics reveals new therapeutic targets for ovarian cancer. PubMed 41577183
- J Ovarian Res, 2025 (senior author): Analysis of microvascular density differences in advanced ovarian cancer after neoadjuvant chemotherapy with or without bevacizumab in real world. PubMed 41390422
- Afr J Reprod Health, 2024 (senior author): Efficacy of concurrent utilization of estradiol valerate and Chinese herbal capsule in managing premature ovarian failure. PubMed 39756042
- Open Life Sci, 2024 (senior author): Human umbilical cord mesenchymal stem cells regulate glutathione metabolism depending on the ERK-Nrf2-HO-1 signal pathway to repair phosphoramide mustard-induced ovarian cancer cells. PubMed 39588114
- Front Oncol, 2024 (senior author): Ovarian steroid cell tumors, not otherwise specified: three case reports and literature review. PubMed 39026973
- Int J Womens Health, 2024 (senior author): Factors Affecting the Diagnostic Discordance Between Frozen and Permanent Sections in Mucinous Ovarian Tumors. PubMed 38774151
- J Cancer, 2024 (senior author): Targeting NEAT1 Affects the Sensitivity to PARPi in Serous Ovarian Cancer by Regulating the Homologous Recombination Repair Pathway. PubMed 38356722
- J Inorg Biochem, 2023 (senior author): The mechanism of copper transporters in ovarian cancer cells and the prospect of cuproptosis. PubMed 37481825
See the full PubMed search. Automatic matching can miss papers or include a namesake at the same hospital.
This profile has not been reviewed by the doctor. How we build this directory.
Want a specialist to review your case?
Send your records. We find a specialist in this field who can review your case and write a treatment plan with a cost estimate.
Get a specialist opinion